These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32943470)

  • 1. Breast cancer prognosis and P-cadherin expression: systematic review and study-level meta-analysis.
    Qi R; Lin J; Chen S; Jiang J; Zhang X; Yao B; Zheng H; Jin Z; Yuan Y; Hou W; Hua B; Guo Q
    BMJ Support Palliat Care; 2022 Dec; 12(e6):e893-e905. PubMed ID: 32943470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of P-cadherin is an indicator of poor prognosis in breast cancer: a systematic review and meta-analysis.
    Sridhar S; Rajesh C; Jishnu PV; Jayaram P; Kabekkodu SP
    Breast Cancer Res Treat; 2020 Jan; 179(2):301-313. PubMed ID: 31664550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
    Wu SY; Tan Y; Guan YS
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
    Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
    Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined expression of ezrin and E-cadherin is associated with lymph node metastasis and poor prognosis in breast cancer.
    Yu Z; Sun M; Jin F; Xiao Q; He M; Wu H; Ren J; Zhao L; Zhao H; Yao W; Shan F; Cao Y; Wei M
    Oncol Rep; 2015 Jul; 34(1):165-74. PubMed ID: 25955302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
    Liu ZF; Chen C; Yao XL; Sun SR
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognositic significance of P-cadherin expression in breast cancer: Protocol for a meta-analysis.
    Xi Y; Zhang X; Yang Z; Zhang X; Guo Q; Zhang Z; Chen S; Zheng H; Hua B
    Medicine (Baltimore); 2019 Mar; 98(12):e14924. PubMed ID: 30896652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathological features and prognosis of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer].
    Wang Y; Zhang S; Zhang H; Liang L; Xu L; Cheng YJ; Duan XN; Liu YH; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):853-862. PubMed ID: 36241228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.
    Wang T; Ma Y; Wang L; Liu H; Chen M; Niu R
    Tumour Biol; 2015 Aug; 36(8):6113-24. PubMed ID: 25804795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cadherin association with clinicopathological features and prognosis in axillary lymph node-positive breast cancer.
    Kong DD; Yang J; Li L; Wang W; Chen YN; Wang SB; Zhou YZ
    Breast Cancer Res Treat; 2015 Feb; 150(1):119-26. PubMed ID: 25677746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
    Gao ZH; Li CX; Liu M; Jiang JY
    BMC Cancer; 2020 Nov; 20(1):1150. PubMed ID: 33238978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of E-cadherin expression in triple-negative breast cancer.
    Kashiwagi S; Yashiro M; Takashima T; Nomura S; Noda S; Kawajiri H; Ishikawa T; Wakasa K; Hirakawa K
    Br J Cancer; 2010 Jul; 103(2):249-55. PubMed ID: 20551954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer.
    Tang D; Xu S; Zhang Q; Zhao W
    Med Oncol; 2012 Jun; 29(2):526-33. PubMed ID: 21519872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of reduced E-cadherin expression in breast cancer: a meta-analysis.
    Li Z; Yin S; Zhang L; Liu W; Chen B
    Oncotarget; 2017 Mar; 8(10):16445-16455. PubMed ID: 28147315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of p53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis.
    Li Y; Zhang X; Qiu J; Pang T; Huang L; Zeng Q
    J BUON; 2019; 24(6):2361-2368. PubMed ID: 31983107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.
    Zhang M; Zhang X; Zhao S; Wang Y; Di W; Zhao G; Yang M; Zhang Q
    Target Oncol; 2014 Dec; 9(4):349-57. PubMed ID: 24233638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the predictive effect of PD-L1 expression on survival in early triple-negative breast cancer].
    Yue J; Wang X; Zhu AJ; Wang DY; Gao SL; Hu NL; Si YR; Zheng FC; Ju J; Wang Z; Yuan P
    Zhonghua Zhong Liu Za Zhi; 2023 Nov; 45(11):948-954. PubMed ID: 37968080
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
    Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
    J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases--aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial.
    Falck AK; Fernö M; Bendahl PO; Rydén L
    BMC Cancer; 2013 Nov; 13():558. PubMed ID: 24274821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer.
    Turashvili G; McKinney SE; Goktepe O; Leung SC; Huntsman DG; Gelmon KA; Los G; Rejto PA; Aparicio SA
    Mod Pathol; 2011 Jan; 24(1):64-81. PubMed ID: 20852590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.